Wisniewski DJ, Voeller D, Addissie YA, Deshmukh SK, et al. EGFR amplification and PI3K pathway mutations identify a subset of breast cancers that synergistically respond to EGFR and PI3K inhibition. Oncogene 2026;45:15-25.
PMID: 41291067